Ceridian HCM Stock Forecast, Price & News

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Ceridian HCM stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDAY, but not buy additional shares or sell existing shares.
View analyst ratings for Ceridian HCM or view top-rated stocks.

Wall Street analysts have given Ceridian HCM a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ceridian HCM wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc. (NYSE:CDAY) released its quarterly earnings results on Wednesday, August, 4th. The company reported $0.06 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.03 by $0.03. The company had revenue of $250.40 million for the quarter, compared to analysts' expectations of $238.48 million. Ceridian HCM had a negative net margin of 6.92% and a negative trailing twelve-month return on equity of 1.15%. The firm's revenue was up 30.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.13 EPS.
View Ceridian HCM's earnings history.

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CDAY stock has increased by 92.8% and is now trading at $109.16.
View which stocks have been most impacted by COVID-19.

Ceridian HCM updated its FY 2021 earnings guidance on Wednesday, September, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.01 billion-$1.02 billion, compared to the consensus revenue estimate of $1 billion.

10 analysts have issued 1-year target prices for Ceridian HCM's stock. Their forecasts range from $87.00 to $120.00. On average, they expect Ceridian HCM's share price to reach $106.33 in the next twelve months. This suggests that the stock has a possible downside of 2.6%.
View analysts' price targets for Ceridian HCM or view top-rated stocks among Wall Street analysts.

902 employees have rated Ceridian HCM CEO David Ossip on Glassdoor.com. David Ossip has an approval rating of 92% among Ceridian HCM's employees. This puts David Ossip in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Ceridian HCM include Autodesk (ADSK), Activision Blizzard (ATVI), Twilio (TWLO), CrowdStrike (CRWD), VMware (VMW), NetEase (NTES), Atlassian (TEAM), Palantir Technologies (PLTR), DocuSign (DOCU), Synopsys (SNPS), Veeva Systems (VEEV), Cadence Design Systems (CDNS), Datadog (DDOG), Roblox (RBLX) and Okta (OKTA).
View all of CDAY's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Advanced Micro Devices (AMD), Alibaba Group (BABA), NVIDIA (NVDA), Adobe (ADBE), Alteryx (AYX), Costco Wholesale (COST), ServiceNow (NOW), Paycom Software (PAYC) and Tesla (TSLA).

(CDAY) raised $420 million in an initial public offering (IPO) on Thursday, April 26th 2018. The company issued 21,000,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities served as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by many different institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (13.40%), Vanguard Group Inc. (8.49%), BlackRock Inc. (8.14%), Cannae Holdings Inc. (8.01%), JPMorgan Chase & Co. (4.10%) and FMR LLC (3.15%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, Christopher R Armstrong, David D Ossip, Gerald C Throop, Jeffrey Scott Jacobs, Leagh Erin Turner, Lisa M Sterling, Scott A Kitching and Thomas H Lee Advisors, Llc.
View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Cannae Holdings Inc., BlackRock Inc., Putnam Investments LLC, Price T Rowe Associates Inc. MD, Millennium Management LLC, Nuveen Asset Management LLC, Russell Investments Group Ltd., and Northern Trust Corp. Company insiders that have sold Ceridian HCM company stock in the last year include Christopher R Armstrong, David D Ossip, Gerald C Throop, Jeffrey Scott Jacobs, and Leagh Erin Turner.
View insider buying and selling activity for Ceridian HCM or view top insider-selling stocks.

CDAY stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, JPMorgan Chase & Co., State Street Corp, Deutsche Bank AG, Echo Street Capital Management LLC, Artisan Partners Limited Partnership, Citigroup Inc., and Amalgamated Bank.
View insider buying and selling activity for Ceridian HCM or or view top insider-buying stocks.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CDAY stock can currently be purchased for approximately $109.16.

Ceridian HCM has a market capitalization of $16.36 billion and generates $842.50 million in revenue each year. The company earns $-4,000,000.00 in net income (profit) each year or $0.14 on an earnings per share basis.

Ceridian HCM employs 5,974 workers across the globe.

The official website for Ceridian HCM is www.ceridian.com.

Ceridian HCM is headquartered at 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at (952) 853-8100 or via email at [email protected].